In a nutshell This study outlines the ESMO guidelines for the diagnosis, treatment and follow-up of Hodgkin lymphoma. Some background Hodgkin lymphoma is a cancer of the lymph system. It mostly occurs in young adults, but can also occur in adults over the age of 55. The European Society for Medical Oncology (ESMO) has recently updated their...
Read More
In a nutshell This study reviewed recommendations for the staging and treatment of Hodgkin lymphoma. Some background Current treatment options for Hodgkin lymphoma have led to a cure rate of 80%. Radiation with or without chemotherapy has become the standard treatment. These treatments, however, can lead to long-term negative effects, such as...
Read More
In a nutshell The aim of this study was to update recommendations on the use of penile implants for erectile dysfunction. Authors concluded that penile implants remain a safe and effective treatment option for erectile dysfunction not responding to other less invasive therapies. Some background Penile prosthetic devices are a treatment option for...
Read MoreIn a nutshell The authors aimed to formulate guidelines for the use of continuous glucose monitoring (CGM) and continuous subcutaneous insulin infusion (CSII) in patients with diabetes. Some background CGM is a technology that involves wearing a small device that tracks blood sugar levels throughout the day and night. This device will...
Read More
In a nutshell This study summarized guidelines for the role of stem cell transplantation in patients with Hodgkin lymphoma. Some background While Hodgkin lymphoma is a curable disease in many, some patients experience a disease relapse or they do not respond to treatment. These patients are often treated with further chemotherapy followed by a...
Read MoreIn a nutshell This article summarized some of the possible late effects of Hodgkin lymphoma treatment. Some background The standard treatment options for Hodgkin lymphoma are radiation and chemotherapy. These treatments have led to very high remission rates (no sign of disease) in many patients. Radiation and chemotherapy have also been associated...
Read More
In a nutshell This paper by the American College of Cardiology and American Heart Association provides recommendation on dual antiplatelet therapy (DAPT). Some background Dual antiplatelet therapy (DAPT) is a treatment for coronary heart disease involving the use of two antiplatelet (blood thinning) drugs. This is usually given...
Read More
In a nutshell This study reviewed recent evidence on drug therapy for erectile dysfunction (ED) and updated recommendations for treatment. Researchers concluded that phosphodiesterase-5 (PDE5) inhibitors remain the first choice due to their excellent safety and effectiveness. Some background Drug therapy is often the first-line treatment...
Read More
In a nutshell This paper looked at the best duration for dual antiplatelet therapy (DAPT) in patients who had a drug-eluting stent or a heart attack. Results showed that patients receiving safer, newer drug-eluting stents may have a minimum DAPT duration of 3 to 6 months. Researchers also noted that the extension of DAPT to more than 1 year...
Read More
In a nutshell In this report, the European Society for Medical Oncology (ESMO) updated recommendations for treating metastatic (spread to other organs) colorectal cancer. Some background Colorectal cancer is one of the most common cancers diagnosed in Europe. Over the last decade in particular, the clinical outcome for patients with metastatic...
Read More
In a nutshell This paper reviews the recent United States guidelines on recommendations for managing cholesterol levels. Some background High levels of cholesterol (type of fat) increases the risk of heart disease. Cholesterol levels can be changed, and medical treatment can help to lower cholesterol levels. Statins, for example, are a group...
Read More
In a nutshell This study summarized updated guidelines for the appropriate treatments for patients with non-small cell lung cancer (NSCLC). Some background Most patients with NSCLC are not diagnosed until the disease is advanced (spread) and survival rates at this late stage of cancer are low. Therefore, it is important that doctors are aware of...
Read More
